home / stock / dtc:cc / dtc:cc news

DTC:CC News and Press, Defence Therapeutics Inc. Class A From 06/20/23

Stock Information
Company Name: Defence Therapeutics Inc. Class A
Stock Symbol: DTC:CC
Market: CNQC
Website: defencetherapeutics.com
Menu
DTC:CC DTC:CC Quote DTC:CC Short DTC:CC News DTC:CC Articles DTC:CC Message Board
Get DTC:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DTC:CC - Defence's Proprietary Accum(TM) Technology for Delivery of CRISPR/Cas Genome-Editing Complexes Patent Application Published

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce...
DTC:CC - Defence Manufacturing of AccuTox(TM) CGMP Final Drug Product Optimization for Its Phase I Clinical Trial at City of Hope

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is ple...

DTC:CC - Defence Begins Testing Its Arm Vaccine Against Pancreatic Cancer

Vancouver, British Columbia--(Newsfile Corp. - June 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is...

DTC:CC - Defence Announces Additional and Final Exercises of Warrants for Gross Proceeds of Over $2.3 Million

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is ple...
DTC:CC - Breakthrough Results: Defence's Arm Vaccine Cured 100% of Animals with Pre-Established Lymphoma

Vancouver, British Columbia--(Newsfile Corp. - May 24, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is plea...

DTC:CC - Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology

2023-05-03 13:49:13 ET Investing in healthcare Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology. The technology helps bio drugs overcome intracellular barriers, making them more effective. Defence is ex...

DTC:CC - Defence's Successful AccuTOX(TM) Pre-Clinical Efficacy Study Complete Ready For Phase I IND Filing

Vancouver, British Columbia--(Newsfile Corp. - May 2, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is pleas...
DTC:CC - Defence Therapeutics Announces Exciting Breakthrough

2023-05-01 16:01:50 ET The treatment of cancer has taken some huge strides forward over the past few decades, but more effective solutions are still urgently needed for a variety of clinical needs. Fortunately, Defence Therapeutics (CSE: DTC, FSE: DTC, OTC: DTCFF) , a Canadian bio...

DTC:CC - USPTO Grants Trademark Registration for Defence Therapeutics(R)

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2023) - Defence Therapeutics Inc. (CSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that the United States Pate...

DTC:CC - Defence Granted US Patent with Broad Coverage on Accum(TM)-based Vaccine Enhancer Platform Technology

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies including Antibod...
Previous 10 Next 10